Stroke and stroke pose growing health challenge
Stroke and stroke are becoming the third most common health problem in developed countries, with a clear upward trend. More than half of these cerebrovascular problems have an inheritable basis, are predictable and are amenable to preventive programs aimed at reducing the risk of cerebrovascular damage.
In more than 70% of cases, strokes are predictable; many of them have a cardiogenic basis and their occurrence depends on the genomic vulnerability of each individual and the lifestyle that can trigger the cerebrovascular crisis. The implementation of personalized preventive programs can minimize the risk in order to avoid the onset of strokes. In those who have already suffered from the disease, personalized therapeutic intervention programs improve functional recovery, damage repair and quality of life.
The impact of latent diseases on managers and executives
More than 60% of managers and executives with great responsibility in their companies, as well as thousands of self-employed people, who have to face their daily work responsibilities, are exposed to the risk of latent or emerging diseases that can condition their lives or those of their companies. Seventy percent of these people have metabolic problems associated with excess cholesterol, triglycerides and/or sugar. 30-40% are at risk of suffering a cardiovascular event. 5-10% may develop cancer. 20-30% are susceptible to nervous system problems, ranging from chronic insomnia, anxiety, depression, headache, dizziness, cerebral ischemia or a highly disabling stroke; and at least 5% of those over 65 will suffer from some type of degenerative, systemic or central disease(Alzheimer's, Parkinson's).
A Comprehensive Approach: The National Health Risk Prevention Plan (PNPRS)
In December 2022 EuroEspes Health announced the launch of a prevention plan for managers and high-risk population, with special attention to neurodegenerative problems (PPA: Alzheimer's Prevention Plan; PPP: Parkinson's Prevention Plan), cardiovascular and cerebrovascular (PPV: Vascular Prevention Plan), and other prevalent diseases.
The International Center for Neuroscience and Genomic Medicine offers the general population and this group of people a National Health Risk Prevention Plan (PNPRS), with a special focus on cardiovascular and cerebrovascular disorders, cancer and diseases of the central nervous system.
The plan consists of the application of a comprehensive medical examination, static and functional imaging tests, an extensive screening of biochemical, hematological, metabolic, neurotransmitter and epigenetic parameters in blood, and a complete genomic profile for risk prediction. This plan is completed with a pharmacogenomic profile to establish preventive and/or therapeutic protocols based on prophylactic or symptomatic treatment programs that make it possible to know with high precision the type of treatment that a person can receive and the treatments to avoid according to his or her personal pharmacogenomic profile.
EuroEspes Health provides the community with a sophisticated genomic screening that makes it possible to identify the risk of strokes of any kind, from migraine and transient ischemic attack to stroke, as the most serious expression of cerebrovascular damage, with a high cost to society and high potential disability for those affected.